 |
|
Switching to Aflibercept in Diabetic Macular Edema after Unsatisfactory Response to Other Anti-vascular Endothelial Growth Factor Drugs
Walid S. Ibrahim, Zeiad H. Eldaly, Mohamed G. Saleh, Mahmoud F. Rateb, Ahmed H. Aldoghaimy
Korean J Ophthalmol. 2019;33(2):122-130. Published online 2019 Apr 8 DOI: https://doi.org/10.3341/kjo.2018.0037
|
|
Citations to this article as recorded by
 Switching to Conbercept in Diabetic Macular Edema After Unsatisfactory Response to Previous Intravitreal Injection of Ranibizumab
Peiyu Xing, Bo Meng, Xiaojia Hu, Wei Qu, Shaowei Wang
Clinical Ophthalmology.2023; Volume 17: 3491. CrossRef Modified early intensive and treat-and-extend regimen of anti-vascular endothelial growth factor for diabetic macular edema in Taiwan
Jui-Feng Chou, Jian-Sheng Wu, Yi-Ling Chen, San-Ni Chen
Scientific Reports.2023;[Epub] CrossRef Switching between anti-VEGF agents in the management of refractory diabetic macular edema: A systematic review
Kian Madjedi, Austin Pereira, Brian G. Ballios, Parnian Arjmand, Peter J. Kertes, Michael Brent, Peng Yan
Survey of Ophthalmology.2022; 67(5): 1364. CrossRef Safety and Outcomes of Intravitreal Aflibercept in Diabetic Macular Edema – A
Systematic Review
Ana Maria Dascalu, Manfredi Rizzo, Ali A. Rizvi, Anca Pantea Stoian, Raluca Claudia Iancu, Daniela Stana, Mihail Silviu Tudosie, Dragos Serban
Current Pharmaceutical Design.2022; 28(21): 1758. CrossRef Changes in metamorphopsia following intravitreal aflibercept injection for diabetic macular edema
Tomoya Murakami, Fumiki Okamoto, Yoshimi Sugiura, Shohei Morikawa, Yoshifumi Okamoto, Takahiro Hiraoka, Tetsuro Oshika
Scientific Reports.2022;[Epub] CrossRef Review of clinical studies and recommendation for a therapeutic flow chart for diabetic macular edema
Shigeo Yoshida, Tomoaki Murakami, Miho Nozaki, Kiyoshi Suzuma, Takayuki Baba, Takao Hirano, Osamu Sawada, Masahiko Sugimoto, Yoshihiro Takamura, Eiko Tsuiki
Graefe's Archive for Clinical and Experimental Ophthalmology.2021; 259(4): 815. CrossRef PF4 antagonizes retinal neovascularization via inhibiting PRAS40 phosphorylation in a mouse model of oxygen-induced retinopathy
Siwei Cai, Qianhui Yang, Yunshan Cao, Yahong Li, Juping Liu, Jiantao Wang, Xiaomin Zhang, Liren Liu, Xiaorong Li, Yan Zhang
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.2020; 1866(3): 165604. CrossRef Anti-VEGF agents in the management of diabetic macular edema
Angela S. Li, Malini Veerappan, Vaishali Mittal, Diana V. Do
Expert Review of Ophthalmology.2020; 15(5): 285. CrossRef
|